Investment

High-profile family office invests in genome dark matter unicorn

One of Switzerland’s most promising biotech companies has been backed by a high-profile life science family office after receiving $1 billion from big pharma last year. 

Subscribe

You will need a Premium+ Subscription to read this article.

Exclusive news, analysis and research on global family enterprise and private investment offices

SUBSCRIBE TODAY

Already have an account? Sign in

You need a Premium subscription.

To read Premium articles please subscribe.

SUBSCRIBE TODAY

Already have an account? Sign in

You've reached the end.

Continue reading free articles by registering as a Member.
Or choose a Premium Plan.

SUBSCRIBE TODAY

Already have an account? Sign in

ATHOS Service
  • Sector: Family Office
  • Country: DE
More Details

What to read next

Investment

A North Carolina-based family office of one of America’s most admired CEOs has invested in a Californian advanced materials group after backing a financial exchange platform for energy markets last November. 
Investment

The family office of an entrepreneur and former hedge fund manager, who sold his business three years ago to KKR, has invested in one of the fastest-growing cafe companies in Europe. 
Investment

A newly founded investment company, set up by the daughter of a billionaire healthcare entrepreneur, is following her father’s passion for life sciences, with help from the family office's chief investment…

Leave a Reply